Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

100 million Americans are now fully vaccinated against COVID-19, according to the CDC's tracker.

Why it matters: That's 38% of the country's adult population — and 55% of the adult population has had at least one shot. All told, the U.S. has administered nearly 240 million shots.

  • That is an enormous success, in such a short time. But, of course, it only gets harder from here — both domestically and globally.

What's next: Moderna is planning to dramatically expand its manufacturing capacity, both to keep up with the extreme global demand and to start making booster shots to address COVID-19 variants.

  • The company upped its minimum expected output for this year, saying it now expects to make at least 800 million doses, and that it'll be able to make as many as 3 billion doses in 2022.

Between the lines: The U.S. has a stranglehold on the Pfizer and Moderna vaccines doses right now, and Moderna said it's increasing its domestic manufacturing capacity by 50%.

  • But it's also making big investments in overseas facilities, which will allow it to serve more of the world.
  • For the first time, Pfizer is now exporting some of the doses it's making in the U.S., Reuters scoops.

Go deeper: mRNA vaccines 94% effective in preventing hospitalization in adults 65 and older

Go deeper

Apr 29, 2021 - Health

De Blasio says New York City plans to "fully reopen" on July 1

Mayor Bill de Blasio announced on MSNBC Thursday that New York City plans to "fully reopen" on July 1, with no restrictions on restaurants, retail, or any other business.

Why it matters: It will be a major milestone for America's most populous city, which was once the global epicenter of the coronavirus pandemic.

Brazil surpasses 400,000 coronavirus deaths

A gravedigger walks among graves of COVID-19 victims in Brazil. Photo: Michael Dantas/AFP via Getty Images

Brazil on Thursday became only the second country to surpass 400,000 coronavirus deaths, according to Johns Hopkins University data.

Why it matters: The rising death toll and high number of cases has some health experts worried about a new wave of the pandemic, exacerbated by the country's slow vaccination campaign and loosening restrictions, AP reports.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!